Panitumumab plus mFOLFOX6 therapy for colorectal cancer patients of RAS wild with potential resectable metastases in relation to early tumor shrinkage
收藏NIAID Data Ecosystem2026-03-08 收录
官方服务：
资源简介：
Primary outcome(s): Early tumor shrinkage(at the point of 8 weeks)
创建时间：
2014-04-15
